(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane

Sensitisation data (human)

Administrative data

Endpoint:

sensitisation data (humans)

Type of information:

other:

Adequacy of study:

supporting study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2007

Report date:

2007

Materials and methods

Type of sensitisation studied:

skin

Study type:

study with volunteers

Test guideline

Qualifier:

no guideline followed

Test material

Test material information

Constituent 1

Test material form:

not specified

Method

Type of population:

general

Ethical approval:

confirmed and informed consent free of coercion received

Route of administration:

dermal